Skip to main content
Top
Published in: Journal of Nephrology 2/2021

01-04-2021 | SARS-CoV-2 | Lessons for the Clinical Nephrologist

COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist

Authors: Timothée Laboux, Jean-Baptiste Gibier, Nicolas Pottier, François Glowacki, Aghilès Hamroun

Published in: Journal of Nephrology | Issue 2/2021

Login to get access

Excerpt

A 57-year-old patient of Congolese origin with a medical history of hypertension under triple therapy was referred to the emergency department due to significant deterioration in general condition, loss of 10 kg in one month, fever, anosmia and ageusia. He also reported a few episodes of non-bloody diarrhea and oliguria. Laboratory findings revealed severe acute kidney failure (serum creatinine at 30.3 mg/dL versus 0.8 mg/dL one month earlier, blood urea nitrogen at 536 mg/dL), hyperkaliemia at 7.4 mmol/L, and low bicarbonatemia at 13 mmol/L (Supplemental table). There was glomerular-range proteinuria with urinary protein-to-creatinine ratio (uPCR) at 1.2 g/g including 0.6 g/g of albuminuria and microscopic hematuria (41/mm3). Normocytic anemia was also noticed (10 g/dL), as was lymphopenia (300/mm3), marked inflammatory syndrome (C-reactive protein 2.5 mg/dL, fibrinogen 0.52 g/dL), and hypoalbuminemia (2.5 g/dL). Etiological assessment showed significant activation of the alternate complement pathway (low C3, normal C4), non-significant titer of anti-nuclear antibodies (1/80), and negative anti-neutrophil cytoplasmic, anti-glomerular basement membrane and anti-PLA2R antibodies. Biological findings also revealed polyclonal hypergammaglobulinemia, normal light chain ratio, and negative cryoglobulinemia. Testing for human immunodeficiency, hepatitis B/C viruses, and syphilis were negative, as were CMV, HHV6, HHV7 and Parvovirus B19 detection by PCR. Finally, nasal and tracheal PCR confirmed acute SARS-CoV-2 infection. The patient initially needed two dialysis sessions. He did not require any oxygen support nor specific treatment for COVID-19 infection. However, given the persisting kidney dysfunction one month later (serum creatinine 2.5 mg/dL and increased uPCR 4.9 g/g), a kidney biopsy was performed, revealing a collapsing variant of focal and segmental glomerulosclerosis (FSGS): histological examination was significant for diffuse hypertrophy and vacuolation of podocyte cytoplasm, diffuse interstitial lymphoplasmacytic infiltrate, and acute tubular necrosis associated with several microcystic tubular dilations (Fig. 1). There was no sign of cellular proliferation within the glomeruli. Immunofluorescence testing revealed mild peripheral and polytypic IgM and C3 deposits within the glomeruli. Electron microscopy did not reveal any foot process effacement, immune deposition, or endothelial tubulo-reticular inclusion. In this context, APOL1 genotyping was performed on a peripheral blood sample with respect to G0 wild type, G1 (rs73885319 and rs60910145) and G2 (rs71785313) SNPs by direct Sanger sequencing. This analysis revealed the rare APOL1 genotype G1GM/G1G+. Four months after admission, renal outcome was globally favorable with serum creatinine stabilization at 1.6 mg/dL and sequelae proteinuria at 1.6 g/g under ACE inhibitors. On a physical level, the patient fully recovered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–839CrossRef Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–839CrossRef
2.
go back to reference Su H, Yang M, Wan C et al (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227CrossRef Su H, Yang M, Wan C et al (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227CrossRef
3.
go back to reference Kissling S, Rotman S, Gerber C et al (2020) Collapsing glomerulopathy in a COVID-19 patient. Kidney Int 98:228–239CrossRef Kissling S, Rotman S, Gerber C et al (2020) Collapsing glomerulopathy in a COVID-19 patient. Kidney Int 98:228–239CrossRef
4.
go back to reference Velez JCQ, Caza T, Larsen CP (2020) COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19. Nat Rev Nephrol 16:565–567CrossRef Velez JCQ, Caza T, Larsen CP (2020) COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19. Nat Rev Nephrol 16:565–567CrossRef
5.
go back to reference Akilesh S, Nast CC, Yamashita M et al (2020) Multicenter clinicopathology correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury of proteinuria. Am J Kidney Dis. S0272-6386(20)31014–3 Akilesh S, Nast CC, Yamashita M et al (2020) Multicenter clinicopathology correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury of proteinuria. Am J Kidney Dis. S0272-6386(20)31014–3
6.
go back to reference Wu H, Larsen CP, Hernandez-Arroyo CF et al (2020) AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high risk genotype. J Am Soc Nephrol 31(8):1688–1695CrossRef Wu H, Larsen CP, Hernandez-Arroyo CF et al (2020) AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high risk genotype. J Am Soc Nephrol 31(8):1688–1695CrossRef
7.
go back to reference Larsen CP, Bourne TD, Wilson JD et al (2020) Collapsing glomerulopathy in patient with COVID-19. Kidney Int Rep 5(6):935–939CrossRef Larsen CP, Bourne TD, Wilson JD et al (2020) Collapsing glomerulopathy in patient with COVID-19. Kidney Int Rep 5(6):935–939CrossRef
8.
go back to reference Kopp JB, Nelson GW, Sampath K et al (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011(22):2129–2137CrossRef Kopp JB, Nelson GW, Sampath K et al (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011(22):2129–2137CrossRef
9.
go back to reference Freedman BI, Limou S, Ma L et al (2018) APOL1-associated-nephropathy: a key contributor to racial disparities in CKD. Am J Kidney Dis 72(5):S8–S16CrossRef Freedman BI, Limou S, Ma L et al (2018) APOL1-associated-nephropathy: a key contributor to racial disparities in CKD. Am J Kidney Dis 72(5):S8–S16CrossRef
10.
go back to reference Gaillard F, Ismael S, Sannier A et al (2020) Tubuloreticular inclusions in COVID-19-related collapsing glomerulopathy. Kidney Int 98(1):241CrossRef Gaillard F, Ismael S, Sannier A et al (2020) Tubuloreticular inclusions in COVID-19-related collapsing glomerulopathy. Kidney Int 98(1):241CrossRef
11.
go back to reference Peleg Y, Kudose S, d’Agati V et al (2020) Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep 5(6):940–945CrossRef Peleg Y, Kudose S, d’Agati V et al (2020) Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep 5(6):940–945CrossRef
12.
go back to reference Nlandu YM, Makulo JRR, Pakasa NM et al (2020) First case of COVID-19-associated collapsing glomerulopathy in sub-Saharan Africa. Case Rep Nephrol 2020:1–5CrossRef Nlandu YM, Makulo JRR, Pakasa NM et al (2020) First case of COVID-19-associated collapsing glomerulopathy in sub-Saharan Africa. Case Rep Nephrol 2020:1–5CrossRef
13.
go back to reference Noble R, Tan MY, McCulloch T et al (2020) Collapsing glomerulopathy affecting native and transplant kidney in individuals with COVID-19. Nephron 144(11):589–594CrossRef Noble R, Tan MY, McCulloch T et al (2020) Collapsing glomerulopathy affecting native and transplant kidney in individuals with COVID-19. Nephron 144(11):589–594CrossRef
14.
go back to reference Malhotra V, Magoon S, Troyer DA et al (2020) Collapsing focal segmental glomerulosclerosis and acute oxalate nephropathy in a patient with COVID-19: a double whammy. J Investig Med High Impact Case Rep 8:2324709620963635PubMedPubMedCentral Malhotra V, Magoon S, Troyer DA et al (2020) Collapsing focal segmental glomerulosclerosis and acute oxalate nephropathy in a patient with COVID-19: a double whammy. J Investig Med High Impact Case Rep 8:2324709620963635PubMedPubMedCentral
15.
go back to reference Sharma P, Uppal NN, Wanchoo R et al (2020) COVID-19-associated kidney injury: a case series of kidney biopsy findings. J Am Soc Nephrol 31(9):1948–1958CrossRef Sharma P, Uppal NN, Wanchoo R et al (2020) COVID-19-associated kidney injury: a case series of kidney biopsy findings. J Am Soc Nephrol 31(9):1948–1958CrossRef
16.
go back to reference Kudose S, Batal I, Santoriello D et al (2020) Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol 31(9):1959–1968CrossRef Kudose S, Batal I, Santoriello D et al (2020) Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol 31(9):1959–1968CrossRef
17.
go back to reference Gupta RK, Bhargava R, Shaukat AA et al (2020) Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases. BMC Nephrol 21(1):326CrossRef Gupta RK, Bhargava R, Shaukat AA et al (2020) Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases. BMC Nephrol 21(1):326CrossRef
18.
go back to reference Deshmukh S, Zhou XJ, Hiser W (2020) Collapsing glomerulopathy in a patient of Indian descent in the setting of COVID-19. Ren Fail 42(1):877–880CrossRef Deshmukh S, Zhou XJ, Hiser W (2020) Collapsing glomerulopathy in a patient of Indian descent in the setting of COVID-19. Ren Fail 42(1):877–880CrossRef
19.
go back to reference Lazareth H, Péré H, Binois Y et al (2020) COVID-19-related collapsing glomerulopathy in a kidney transplant recipient. Am J Kidney Dis 76(4):590–594CrossRef Lazareth H, Péré H, Binois Y et al (2020) COVID-19-related collapsing glomerulopathy in a kidney transplant recipient. Am J Kidney Dis 76(4):590–594CrossRef
20.
go back to reference Kadosh BS, Pavone J, Wu M et al (2020) Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient. J Heart Lung Transplant 39(8):855–857CrossRef Kadosh BS, Pavone J, Wu M et al (2020) Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient. J Heart Lung Transplant 39(8):855–857CrossRef
21.
go back to reference Magoon S, Bichu P, Malhotra V et al (2020) COVID-19-related glomerulopathy: a report of 2 cases of collapsing focal segmental glomerulosclerosis. Kidney Med 2(4):488–492CrossRef Magoon S, Bichu P, Malhotra V et al (2020) COVID-19-related glomerulopathy: a report of 2 cases of collapsing focal segmental glomerulosclerosis. Kidney Med 2(4):488–492CrossRef
Metadata
Title
COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist
Authors
Timothée Laboux
Jean-Baptiste Gibier
Nicolas Pottier
François Glowacki
Aghilès Hamroun
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2021
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-020-00935-6

Other articles of this Issue 2/2021

Journal of Nephrology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.